Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine elimination in adolescents with psychiatric disorders
2007-005716-64Phase 4Completed
- Sponsor
- Universitätsklinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine and midazolam in schizophrenia, bipolar disorder (BD), impulse control disorder (ICD) and 2 more, sponsored by Universitätsklinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters. Started Aug 2008; status: completed.
02
Drugs
quetiapinemidazolam
03
Conditions
schizophreniabipolar disorder (BD)impulse control disorder (ICD)post-traumatic stress disorder (PTSD)personality disorder (PD)
Beyond the preview
Go deeper on 2007-005716-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005716-64.